Corrigendum to “Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency”

Corrigendum to “Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency”

Bibliographic Details
Main Authors:	Samar Rahhal, Cristan Farmer, Audrey Thurm, Christopher A. Wassif, Niamh X. Cawley, John Perreault, An Dang Do, Simona Bianconi, Fady Hannah-Shmouni, Whitney Guthrie, Laura S. Cubit, Judith S. Miller, V. Reid Sutton, Dwight Koeberl, Forbes D. Porter
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Molecular Genetics and Metabolism Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214426923000599

Similar Items

Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency
by: Samar Rahhal, et al.
Published: (2023-12-01)

Rare disease variant curation from literature: assessing gaps with creatine transport deficiency in focus
by: Erica L. Lyons, et al.
Published: (2023-08-01)

Classifying and characterizing the development of adaptive behavior in a naturalistic longitudinal study of young children with autism
by: Cristan Farmer, et al.
Published: (2018-01-01)

Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study
by: Cristan Farmer, et al.
Published: (2023-01-01)

State of the Field: Differentiating Intellectual Disability From Autism Spectrum Disorder
by: Audrey Thurm, et al.
Published: (2019-07-01)

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
by: Rosengren Lars, et al.
Published: (2009-12-01)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2016-08-01)

Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation
by: Lenka Fialova, et al.
Published: (2017-09-01)

Three cases of multi-generational Gaucher disease and colon cancer from an Ashkenazi Jewish family: A lesson for cascade screening
by: Fady Hannah-Shmouni, et al.
Published: (2019-03-01)

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke
by: Ann De Vos, et al.
Published: (2017-08-01)

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)

The diagnostic value of cerebrospinal fluid tau protein in dementing neuropsychiatric disorders
by: Mamali Ioanna, et al.
Published: (2006-02-01)

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
by: Shorena Janelidze, et al.
Published: (2020-04-01)

Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations
by: Jessica Brown, et al.
Published: (2023-04-01)

Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy
by: Nora Möhn, et al.
Published: (2019-09-01)

Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
by: Ross W. Paterson, et al.
Published: (2015-09-01)

Effect of long‐term storage in biobanks on cerebrospinal fluid biomarker Aβ1‐42, T‐tau, and P‐tau values
by: Eline A.J. Willemse, et al.
Published: (2017-01-01)

Myocardial creatine uptake is regulated by the sarcolemmal fraction of the creatine transporter, but not by the total creatine transporter pool
by: Boehm, E, et al.
Published: (2002)

Creatine and creatine kinase in health and disease [electronic resource]: /
by: Salomons, Gajja S., et al.
Published: (2007)

Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels
by: Taylor J. Maxwell, et al.
Published: (2018-08-01)

The contribution of platelets to peripheral BDNF elevation in children with autism spectrum disorder
by: Cristan A. Farmer, et al.
Published: (2021-09-01)

Simultaneous decreases in the creatine transporter, creatine content and creatine kinase in an experimental dog model of heart failure
by: Boehm, E, et al.
Published: (2001)

Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers
by: Anna L. Wojdała, et al.
Published: (2025-01-01)

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
by: Johan Gobom, et al.
Published: (2022-12-01)

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
by: Joery Goossens, et al.
Published: (2018-03-01)

Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
by: Zhiva Skachokova, et al.
Published: (2019-05-01)

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
by: Pieter Jelle Visser, et al.
Published: (2022-03-01)

Creatine in the brain
by: Yuko Kurosawa, et al.
Published: (2017-07-01)

Creatine supplementation and endurance performance: surges and sprints to win the race
by: Scott C. Forbes, et al.
Published: (2023-12-01)

Regulation of Myocardial Creatine Uptake by Intra- and Extracellular Creatine Levels
by: Makinen, K, et al.
Published: (2008)

Creatine uptake in mouse hearts with genetically altered creatine levels.
by: ten Hove, M, et al.
Published: (2008)

Comparison of new forms of creatine in raising plasma creatine levels
by: Purpura Martin, et al.
Published: (2007-11-01)

Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase
by: Peter Klivenyi, et al.
Published: (2004-04-01)

Creatine supplementation: effects on blood creatine kinase activity responses to resistance exercise and creatine kinase activity measurement
by: Marco Machado, et al.
Published: (2009-12-01)

Differences in sleep EEG coherence and spindle metrics in toddlers with and without receptive/expressive language delay: a prospective observational study
by: Xinyi Hong, et al.
Published: (2025-02-01)

Expanding the Clinical Spectrum of LONP1-Related Mitochondrial Cytopathy
by: Fady Hannah-Shmouni, et al.
Published: (2019-10-01)

Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology
by: Alessandro Padovani, et al.
Published: (2025-01-01)

Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: a pilot study
by: Roman Sattarov, et al.
Published: (2024-10-01)

Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
by: Gro Gujord Tangen, et al.
Published: (2023-02-01)

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
by: Umesh Gangishetti, et al.
Published: (2018-09-01)